PRODUCTION, ANALYSIS, AND DISTRIBUTION OF CANNABIS AND RELATED MATERIALS. POP: MARCH 23, 2015 - MARCH 22, 2020. N01DA-15-7793.

大麻及相关材料的生产、分析和分销。

• 批准号: 10042112
• 负责人: ELSOHLY MAHMOUD A.
• 金额: $ 198.14万
• 依托单位: UNIVERSITY OF MISSISSIPPI
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-03-23 至 2020-03-22
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10042112
• 关键词: Authorization documentation; Cannabidiol; Cannabinoids; Cannabis; Cigarette; Contracts; Equipment and supply inventories; Exercise; Harvest; Marijuana; Methods; National Institute of Drug Abuse; Pharmaceutical Preparations; Plants; Process; Research; Research Personnel; Standardization; Tetrahydrocannabinol; programs

To exercise Option Period 4 (Contract Year 5); $1,669,640. To exercise Option Quantity 2b (Contract Year 4): $311,759. In brief, the objectives are to: (1) cultivate and harvest, process, analyze, store, and distribute cannabis (marijuana) for research; (2) extract cannabis to produce pure and standardized (current Good Manufacturing Practices (cGMP)­ grade) cannabis extracts containing varying concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD); (3) isolate cGMP and research grade THC, CBD, and other cannabinoids; (4) periodically analyze cannabis extracts, and isolated cannabinoids for authenticity, purity and stability; (5) develop new methods for growing cannabis plants containing high THC, low CBD; high CBD, low THC; and equal strength of CBD and THC; (6) manufacture, analyze, determine stability, store, and supply marijuana cigarettes; and (7) supply cannabis, cannabis extract, other cannabinoids, and marijuana cigarettes to research investigators and/or to the NIDA Drug Supply program upon NIDA authorization.

行使期权期4（合同年5）; 1669640美元。 行使期权数量2b（合同年4）：311 759美元。 简而言之，目标是：（1）培养和收获，加工，分析，储存和分配 大麻（marijuana）用于研究;（2）提取大麻以生产纯的和标准化的（当前 良好生产规范（cGMP）的大麻提取物，含有不同浓度的 δ-9-四氢大麻酚（THC）和大麻二酚（CBD）;（3）分离cGMP和研究级THC， CBD和其他大麻素;（4）定期分析大麻 提取物和分离的大麻素的真实性，纯度和稳定性;（5）开发新的方法 用于种植含有高THC，低CBD的大麻植物;高CBD，低THC;和同等强度的 CBD和THC;（6）制造，分析，确定稳定性，储存和供应大麻香烟; 及（7）供应大麻、大麻提取物、其他大麻素及大麻香烟， 研究人员和/或NIDA药物供应计划 擅自